BI 3731579

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

CompletedNCT06429137

Boehringer IngelheimHealthy

Start: 2024-07-08End: 2025-05-27Updated: 2026-08-10

A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood

CompletedNCT06861829

Boehringer IngelheimHealthy

Start: 2025-03-19End: 2025-04-23Updated: 2026-08-11